Unfolding Novel Mechanisms of Polyphenol Flavonoids for Better Glycaemic Control: Targeting Pancreatic Islet Amyloid Polypeptide (IAPP).

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28754022)

Published in Nutrients on July 21, 2017

Authors

Ivana R Sequeira1,2, Sally D Poppitt3,4,5

Author Affiliations

1: Human Nutrition Unit, School of Biological Sciences, University of Auckland, Auckland 1010, New Zealand. i.sequeira@auckland.ac.nz.
2: High-Value Nutrition National Science Challenge, Auckland 1142, New Zealand. i.sequeira@auckland.ac.nz.
3: Human Nutrition Unit, School of Biological Sciences, University of Auckland, Auckland 1010, New Zealand. s.poppitt@auckland.ac.nz.
4: High-Value Nutrition National Science Challenge, Auckland 1142, New Zealand. s.poppitt@auckland.ac.nz.
5: Department of Medicine, University of Auckland, Auckland 1142, New Zealand. s.poppitt@auckland.ac.nz.

Articles cited by this

(truncated to the top 100)

Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med (2002) 101.79

Banting lecture 1988. Role of insulin resistance in human disease. Diabetes (1988) 33.22

Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract (2009) 25.83

Biochemistry and molecular cell biology of diabetic complications. Nature (2001) 25.43

National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet (2011) 19.21

Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes (2003) 16.62

10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet (2009) 15.00

Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet (2006) 11.64

Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ (2007) 10.06

The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet (2008) 9.03

The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia (2006) 8.18

Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease. Brain (2007) 6.39

Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr (2005) 6.05

Diabetes in Asia. Lancet (2009) 5.96

Unfolding the role of protein misfolding in neurodegenerative diseases. Nat Rev Neurosci (2003) 4.75

Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci U S A (1987) 4.53

Dietary intake and bioavailability of polyphenols. J Nutr (2000) 4.49

Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet (2016) 4.29

Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy. Nat Med (1998) 4.17

Dietary polyphenols and the prevention of diseases. Crit Rev Food Sci Nutr (2005) 3.86

Flavonoid intake and risk of chronic diseases. Am J Clin Nutr (2002) 3.57

A possible role for pi-stacking in the self-assembly of amyloid fibrils. FASEB J (2002) 3.34

The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. Diabetes (1999) 3.30

Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diabetes Res (1988) 3.10

Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes. J Clin Endocrinol Metab (2004) 2.92

Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis. Endocr Rev (2008) 2.79

Lifestyle risk factors and new-onset diabetes mellitus in older adults: the cardiovascular health study. Arch Intern Med (2009) 2.72

The flavonoids. A class of semi-essential food components: their role in human nutrition. World Rev Nutr Diet (1976) 2.63

Diabetes: a 21st century challenge. Lancet Diabetes Endocrinol (2013) 2.55

EGCG remodels mature alpha-synuclein and amyloid-beta fibrils and reduces cellular toxicity. Proc Natl Acad Sci U S A (2010) 2.48

Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid. Diabetes (2003) 2.46

Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer's disease. J Neurosci (2006) 2.45

Dietary factors determining diabetes and impaired glucose tolerance. A 20-year follow-up of the Finnish and Dutch cohorts of the Seven Countries Study. Diabetes Care (1995) 2.44

The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus. Diabetologia (1978) 2.31

Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane. Proc Natl Acad Sci U S A (2008) 2.25

Diabetes prevention in the real world: effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes and of the impact of adherence to guideline recommendations: a systematic review and meta-analysis. Diabetes Care (2014) 2.21

Will China's nutrition transition overwhelm its health care system and slow economic growth? Health Aff (Millwood) (2008) 2.15

Estimated dietary flavonoid intake and major food sources of U.S. adults. J Nutr (2007) 2.14

Pore formation by the cytotoxic islet amyloid peptide amylin. J Biol Chem (1996) 2.01

Improved lifestyle and decreased diabetes risk over 13 years: long-term follow-up of the randomised Finnish Diabetes Prevention Study (DPS). Diabetologia (2012) 1.99

Cortisol secretion in patients with type 2 diabetes: relationship with chronic complications. Diabetes Care (2007) 1.97

Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxid Redox Signal (2012) 1.96

Biomarkers of the intake of dietary polyphenols: strengths, limitations and application in nutrition research. Br J Nutr (2007) 1.95

Chemistry and biochemistry of dietary polyphenols. Nutrients (2010) 1.90

Interaction between phenolics and gut microbiota: role in human health. J Agric Food Chem (2009) 1.86

Dietary flavonoid intakes and risk of type 2 diabetes in US men and women. Am J Clin Nutr (2012) 1.84

Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options? Eur J Clin Invest (2009) 1.82

Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide. Proc Natl Acad Sci U S A (1996) 1.81

Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and beta-cell damage in rat pancreas. Pharmacol Res (2005) 1.79

Impact of dietary polyphenols on carbohydrate metabolism. Int J Mol Sci (2010) 1.78

Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man. FEBS Lett (1997) 1.76

Redefining type 2 diabetes: 'diabesity' or 'obesity dependent diabetes mellitus'? Obes Rev (2000) 1.76

Prevention and management of type 2 diabetes: dietary components and nutritional strategies. Lancet (2014) 1.75

The aggregation potential of human amylin determines its cytotoxicity towards islet beta-cells. FEBS J (2006) 1.68

The flavanol (-)-epigallocatechin 3-gallate inhibits amyloid formation by islet amyloid polypeptide, disaggregates amyloid fibrils, and protects cultured cells against IAPP-induced toxicity. Biochemistry (2010) 1.63

Comparative evaluation of quercetin, isoquercetin and rutin as inhibitors of alpha-glucosidase. J Agric Food Chem (2009) 1.63

Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiology. Biochim Biophys Acta (2001) 1.63

Amyloid peptides are toxic via a common oxidative mechanism. Proc Natl Acad Sci U S A (1995) 1.60

β-cell loss and β-cell apoptosis in human type 2 diabetes are related to islet amyloid deposition. Am J Pathol (2011) 1.59

Pharmacokinetics and bioavailability of quercetin glycosides in humans. J Clin Pharmacol (2001) 1.57

Associations of dietary flavonoids with risk of type 2 diabetes, and markers of insulin resistance and systemic inflammation in women: a prospective study and cross-sectional analysis. J Am Coll Nutr (2005) 1.57

Dietary flavonoid and isoflavone glycosides are hydrolysed by the lactase site of lactase phlorizin hydrolase. FEBS Lett (2000) 1.56

Small-molecule conversion of toxic oligomers to nontoxic β-sheet-rich amyloid fibrils. Nat Chem Biol (2011) 1.54

Polyphenolic phytochemicals--just antioxidants or much more? Cell Mol Life Sci (2007) 1.53

Evidence for proteotoxicity in beta cells in type 2 diabetes: toxic islet amyloid polypeptide oligomers form intracellularly in the secretory pathway. Am J Pathol (2009) 1.53

Lymphatic absorption of quercetin and rutin in rat and their pharmacokinetics in systemic plasma. J Agric Food Chem (2010) 1.50

Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle. Proc Natl Acad Sci U S A (1988) 1.47

Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am J Clin Nutr (1995) 1.45

Pancreatic islet amyloidosis, beta-cell apoptosis, and alpha-cell proliferation are determinants of islet remodeling in type-2 diabetic baboons. Proc Natl Acad Sci U S A (2009) 1.45

Antihyperglycaemic and antioxidant effect of rutin, a polyphenolic flavonoid, in streptozotocin-induced diabetic wistar rats. Basic Clin Pharmacol Toxicol (2006) 1.45

Quantitative studies on amyloid in the islets of Langerhans. Ups J Med Sci (1972) 1.42

Vegetable but not fruit consumption reduces the risk of type 2 diabetes in Chinese women. J Nutr (2008) 1.42

Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver beta-glucosidase activity. FEBS Lett (1998) 1.42

Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance. J Clin Endocrinol Metab (1987) 1.40

A prospective study of the association between quantity and variety of fruit and vegetable intake and incident type 2 diabetes. Diabetes Care (2012) 1.35

Metabolic fate of polyphenols in the human superorganism. Proc Natl Acad Sci U S A (2010) 1.34

Longitudinal studies on the development of diabetes in individual Macaca nigra. Diabetologia (1986) 1.34

Human amylin oligomer growth and fibril elongation define two distinct phases in amyloid formation. J Biol Chem (2004) 1.33

Dietary polyphenols as potential nutraceuticals in management of diabetes: a review. J Diabetes Metab Disord (2013) 1.32

THE RELATION OE DIABETES MELLITUS TO LESIONS OF THE PANCREAS. HYALINE DEGENERATION OF THE ISLANDS OE LANGERHANS. J Exp Med (1901) 1.31

11beta-hydroxysteroid dehydrogenase type 1 regulates glucocorticoid-induced insulin resistance in skeletal muscle. Diabetes (2009) 1.29

Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease. Neuroimage Clin (2013) 1.21

Anti-amyloidogenic activity of tetracyclines: studies in vitro. FEBS Lett (2001) 1.21

Aromatic small molecules remodel toxic soluble oligomers of amyloid beta through three independent pathways. J Biol Chem (2010) 1.20

The sugar moiety is a major determinant of the absorption of dietary flavonoid glycosides in man. Free Radic Res (1999) 1.20

Effects of salt bridges on protein structure and design. Protein Sci (1998) 1.20

Inhibiting islet amyloid polypeptide fibril formation by the red wine compound resveratrol. Chembiochem (2009) 1.18

Type 2 diabetes as a disease of ectopic fat? BMC Med (2014) 1.17

Systematic analysis of the content of 502 polyphenols in 452 foods and beverages: an application of the phenol-explorer database. J Agric Food Chem (2010) 1.17

Amyloidosis: a review of recent diagnostic and therapeutic developments. Br J Haematol (1997) 1.14

Diet-derived phenols in plasma and tissues and their implications for health. Planta Med (2004) 1.14

Analysis of the inhibition and remodeling of islet amyloid polypeptide amyloid fibers by flavanols. Biochemistry (2012) 1.13

Relationship between glucose tolerance, insulin secretion, and insulin action in non-obese individuals with varying degrees of glucose tolerance. Diabetologia (1989) 1.13

Antioxidant actions of flavonoids: thermodynamic and kinetic analysis. Arch Biochem Biophys (2010) 1.10

Fibrillogenic amylin evokes islet beta-cell apoptosis through linked activation of a caspase cascade and JNK1. J Biol Chem (2003) 1.10

The association between dietary flavonoid and lignan intakes and incident type 2 diabetes in European populations: the EPIC-InterAct study. Diabetes Care (2013) 1.10

Quercetin attenuates fasting and postprandial hyperglycemia in animal models of diabetes mellitus. Nutr Res Pract (2011) 1.09

Impaired glucose tolerance and insulin resistance are associated with increased adipose 11beta-hydroxysteroid dehydrogenase type 1 expression and elevated hepatic 5alpha-reductase activity. Diabetes (2008) 1.08

Calcium-activated calpain-2 is a mediator of beta cell dysfunction and apoptosis in type 2 diabetes. J Biol Chem (2009) 1.08

Bioavailability, bioactivity and impact on health of dietary flavonoids and related compounds: an update. Arch Toxicol (2014) 1.06